1. Contractors
  2. International Aids Vaccine Initiative Inc.

International Aids Vaccine Initiative Inc.

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

International Aids Vaccine Initiative has 15 federal contracts of $100,000 or more active since October 2023, with $148M obligated, from 3 agencies. 7 are still running, 4 ending within 18 months.

Contracts
15 since FY2024$148,438,324 obligated, contracts of $100,000 or more
Running now
7 contracts
Biggest customer
Office of Assistant Secretary for Preparedness and Response$95.6M on 1 contract
UEI
ZEJBC8JQM3P5Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2020$256,138
FY2021$125,245,287
FY2022$8,398,301
FY2023$3,625,389

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Contract HHSN272201800010I International Aids Vaccine Initiative Manufacture of Influenza Virus Human Challenge Material for Phase I and II Clinical TestingNational Institutes of Health · 75N93023F00001$3,625,389Dec 31, 2026in 1 monthNY
1800010I International Aids Vaccine Initiative to V3 Obra 2 Base Task Order Funding Biod Can 8470038 $642,953National Institutes of Health · 75N93019F00131$2,203,474Apr 30, 2028in 17 monthsNY
HHSN272201800010I Iavi Storage of Gmp and Non-Gmp Materials for Niaid Base Award, Can 8470038 for $435,313.50 Can 8040917 for $435,313.50 Total $870,627National Institutes of Health · 75N93021F00001$963,185Apr 30, 2028in 17 monthsNY
1800010I International Aids Vaccine Initiative Manufacture of Human Flu Challenge MaterialNational Institutes of Health · 75N93018F00002$4,151,337May 14, 2028in 17 monthsNY
This Task Order Is to Develop an Optimized Phase 1 Cgmp Manufacturing Process for Lipid Nanoparticle (Lnp) Fabrication That Enable Covalent Coupling of an Hiv-1 Env Trimer to the Surface of the Lnp…National Institutes of Health · 75N93021F00239$2,250,342Aug 31, 2028in 21 monthsNY
The Overall Objective of This Contract Is to Advance the Development of Monovalent Vaccines for Prevention of Marburg Virus (Marv) and Sudan Ebolavirus (Sudv) Disease. These Vaccines Are Based on…Office of Assistant Secretary for Preparedness and Response · 75A50121C00077$95,592,504Dec 31, 2028in 25 monthsNY
Preclinical and Translational Vaccine Development for Hiv and Other Candidate AgentsNational Institutes of Health · 75N93022F00001$8,398,301Aug 29, 2030in 45 monthsNY

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Office of Assistant Secretary for Preparedness and Response1 contract$95,592,504
National Institutes of Health13 contracts$26,584,354
Defense Threat Reduction Agency1 contract$26,261,466

Where the work is

Place of workAmount, $M
New York15 contracts148.4

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.

Get new notices like International Aids Vaccine Initiative's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy